SUMMARY C reactive protein (CRP) was measured serially in 29 patients with infective endocarditis. Twenty one patients were initially treated with antimicrobial drugs. In 13, serial measurement ofCRP concentrations showed a progressive return to normal (less than 10 mg/l), which correlaWd with a satisfactory recovery. Of the remainder (eight patients), five had persistently high concentrations of CRP, indicating a failure to respond to antimicrobial treatment alone. Two of these five patients died and three underwent valve replacement. Of 11 patients treated with antibiotics and valve replacement, CRP concentrations returned to normal in nine. Two patients had infective complications and the CRP concentration did not return to normal. A transient rise in CRP concentration during an otherwise uneventful fall to normal was a sign of allergic reaction in two and of intercurrent infection in three more patients. Serial measurements of CRP concentrations in patients with infective endocarditis may be useful to monitor treatment and also to detect other infections and complications.
Infective endocarditis has a mortality of about 30% despite improvements in treatment with antimicrobial agents and valve replacement.' Although the infection usually responds to appropriate antibiotics, fever and intercurrent infection can develop and may complicate clinical assessment of the response to treatment. Although the serum bactericidal test is widely used to assess the response, there is little evidence to date that the test is of prognostic value. 2 C reactive protein (CRP) is an acute phase protein of the serum, concentrations of which can increase rapidly in response to tissue injury, infection, or inflammation in healthy subjects. When the stimulus resolves, such as with effective antimicrobial treatment, the concentration falls rapidly. 3 The development of immunochemical assay methods means that serum CRP concentrations can now be measured quickly and accurately.
Serial CRP measurements have proved useful in monitoring the response to antimicrobial treatment in neonatal septicaemia,6 infections of the central nervous system,7" infections in leukaemia,9 and peritonitis in patients receiving continuous peritoneal dialysis.'°W e recently examined the clinical value ofdetermining serial CRP concentrations in a prospective study of patients with infective endocarditis. Serial CRP measurements provided a useful and rapid index ofthe Accepted for publication 8 July 1987 44 response to treatment in endocarditis and also indicated the duration of treatment.
Patients and methods
Twenty nine patients with infective endocarditis were studied between November 1983 and September 1986; 17 were male and 12 female, with a mean age of 43 6 years (range 14-71). Where possible, a blood sample was taken as soon as the diagnosis ofendocarditis was confirmed in the laboratory. Thereafter, CRP concentrations were measured regularly every one to two days. CRP was estimated by fluorescence polarimetry (Abbott Laboratories, Diagnostic Division). The intra-assay coefficient of variation was less than 5% and a CRP concentration of 10 mg/l or less was regarded as normal."
Tests for serum bactericidal titre (SBT fig 2 shows valves observed in a control group of patients who had cardiac surgery with an uneventful postoperative course. The mean time after surgery when the serum CRP concentration returned to normal in nine of the 1 I patients with endocarditis was 17 days (range eight to 24). Unfortunately, one patient died from a spontaneous splenic rupture. In two patients, CRP did not return to normal: one patient became superinfected with C albicans and died during an operation for valve re-replacement and the other died from a cerebral mycotic aneurysm (fig 3) .
Three patients developed intercurrent infections during treatment for infective endocarditis: these included a chest infection with Haemophilus influenzae, vaginitis due to C albicans (fig 4) , and a perineal abscess from which both Bacteroides fragilis and Enterobacter cloacae were cultured. 
Discussion
This study reports the results of serial CRP measurements in 29 patients with infective endocarditis. In 22 the CRP concentrations progressively returned to normal and this correlated with a satisfactory response to treatment. In this group a transient increase in CRP concentrations during the fall to within normal limits was a sign of allergic drug reaction in two patients and of intercurrent infection in three more. In the group of 21 patients initially treated with antimicrobial agents alone persistent high concentrations of CRP in five patients corresponded with a failure to respond to treatment (table 2) . Two patients, whose treatment had been discontinued while CRP was still raised, relapsed. This suggests, perhaps, that CRP determining concentration may also be of value in decisions on the duration of treatment in infective endocarditis.
A rise in serum CRP is a non-specific acute phase Surgery Days after surgery Microbiologists generally use in vitro tests of the serum inhibitory titre and the serum bactericidal titre to assess the response to antimicrobial agents in infective endocarditis. Coleman reviewed 17 individual studies which attempted to correlate serum inhibitory titre and serum bactericidal titre with therapeutic outcome.2 He concluded that there was insufficient evidence for these tests to be used as prognostic indicators in patients with endocarditis. In a multicentre collaborative evaluation Weinstein et al showed that serum bactericidal titre can predict bacteriological cure but not bacteriological failure or clinical outcome.'2 This may reflect the influence of other factors on the outcome besides the causal organism and appropriate treatment. Our study suggests that serial measurements of serum CRP concentrations are of more value than estimations of serum bactericidal titre both in prognosis and in predicting continuing infection in infective endocarditis.
The magnitude ofthe CRP response has been shown to correlate well with the severity of tissue damage in several infectious, inflammatory, and neoplastic disorders.5 In our study there was some evidence that the magnitude of the CRP response correlated with the pathogenicity of the infecting organisms and the tissue damage of the infected valve.
Rapid and precise assays for CRP are now commercially available. This study shows that serial measurements ofCRP can be used both to monitor the response to antimicrobial treatment in infective endocarditis and also to detect other infections and complications. As with many in vitro tests, however, CRP values must not be interpreted without knowing the clinical picture and other laboratory results. 
